Phospholipase A2, Group IB (PLA2G1B) Peptide
PLA2G1B
Reactivity: Human, Dog
Host: Synthetic
BP, Imm
-
- Target See all PLA2G1B products
- PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))
- Origin
- Human, Dog
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Immunogen (Imm)
- Sequence
- NKAHKNLDTK KYCQS
- Characteristics
- The peptide was used in the production of ABIN370261 - Goat Anti-PLA2G1B Antibody. It is currently untested in blocking applications.
-
-
- Application Notes
- When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
- Buffer
- 100µg of Lyophilised peptide, formulation De-ionized (DI) water.
- Storage
- -20 °C
- Storage Comment
- Shipped at ambient temperature, store at -20°C.
-
- Target
- PLA2G1B (Phospholipase A2, Group IB (PLA2G1B))
- Synonyms
- C133 Peptide, CG4346 Peptide, Dmel\\CG42237 Peptide, Dmel_CG4346 Peptide, PLA2 Peptide, GB13351 Peptide, bvPLA2 Peptide, PLA2A Peptide, PPLA2 Peptide, sPLA(2)-IB Peptide, Pla2a Peptide, sPLA2IB Peptide, PLA2G1B Peptide, CG42237 gene product from transcript CG42237-RB Peptide, phospholipase A2 Peptide, phospholipase A2 group IB Peptide, phospholipase A2, group IB, pancreas Peptide, phospholipase A2 group IVA Peptide, CG42237 Peptide, PLA2 Peptide, LOC100631065 Peptide, Pla2 Peptide, PLA2G1B Peptide, Pla2g1b Peptide, PLA2G4A Peptide
-
You are here:
